Professor Warren H. Finlay is the founding Director of the Aerosol Research Laboratory of Alberta (ARLA). After receiving his Ph.D. from Stanford University in 1987, he joined the University of Alberta as an Assistant Professor, was promoted to the rank of Professor in 1993, and awarded the title of Distinguished University Professor in 2017. He has published numerous journal articles on the mechanics of inhaled pharmaceutical aerosols, as well as more traditional engineering fields (see Publications), and has taught widely at the University of Alberta at both the undergraduate and graduate levels. His laboratory is the originator of the Alberta Idealized Throat, which is sold worldwide by Copley Scientific (UK) for inhaler testing.
He is Editor in Chief of Aerosol Science and Technology, and is the author of a book entitled "The Mechanics of Inhaled Pharmaceuticals Aerosols: An Introduction", published by Academic Press. He is the Canada Research Chair in Aerosol Mechanics. He is also the recipient of various academic awards for outstanding achievement, including lifetime designations as a Fellow of the Royal Society of Canada (2014), Fellow of the Engineering Institute of Canada (2011) and Fellow of the American Association for Aerosol Research (2009), the International Society for Aerosols in Medicine Career Achievement Award (2017), the Charles G. Thiel Award (2016), the ASTech Outstanding Leadership in Alberta Science Award (2014), the APEGGA Centennial Leadership Award (2009), the joint American Association of Aerosol Research and International Society for Aerosols in Medicine Thomas T. Mercer Prize (2008), the APEGGA Summit/Alberta Ingenuity Fund Research Excellence Award (2006), a Killam Annual Professorship (2005-2006), 1st prize at the Association of Health Technologies Industry 7th Innovation Research Contest (2004), the International Society for Aerosols in Medicine Young Investigators Award (2001), McCalla Research Professor, the Birks Gold Medal in Engineering, and the NSERC 1967 Research Scholarship, among others. He works extensively with companies around the world on drug delivery to the lungs and is devoted to the fight against lung disease.